CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $258,000 | -54.5% | 212,150 | -36.0% | 0.00% | – |
Q2 2022 | $567,000 | +1081.2% | 331,684 | +1070.5% | 0.00% | – |
Q1 2022 | $48,000 | +60.0% | 28,336 | +491.2% | 0.00% | – |
Q2 2021 | $30,000 | -36.2% | 4,793 | -32.8% | 0.00% | – |
Q1 2021 | $47,000 | -88.0% | 7,136 | -89.7% | 0.00% | – |
Q4 2020 | $391,000 | -45.9% | 69,597 | -45.9% | 0.00% | – |
Q3 2020 | $723,000 | -63.0% | 128,604 | -55.9% | 0.00% | -100.0% |
Q2 2020 | $1,953,000 | +128.7% | 291,449 | +107.2% | 0.00% | +100.0% |
Q1 2020 | $854,000 | -57.8% | 140,656 | -27.5% | 0.00% | -50.0% |
Q4 2019 | $2,024,000 | +154.6% | 194,077 | -4.0% | 0.00% | – |
Q3 2019 | $795,000 | +455.9% | 202,249 | +1995.4% | 0.00% | – |
Q2 2019 | $143,000 | -6.5% | 9,652 | +55.8% | 0.00% | – |
Q1 2019 | $153,000 | +14.2% | 6,195 | -16.7% | 0.00% | – |
Q4 2018 | $134,000 | -87.3% | 7,438 | -79.4% | 0.00% | -100.0% |
Q3 2018 | $1,059,000 | +47.1% | 36,045 | +127.7% | 0.00% | 0.0% |
Q2 2018 | $720,000 | +2017.6% | 15,831 | +2420.9% | 0.00% | – |
Q1 2018 | $34,000 | -90.2% | 628 | -87.6% | 0.00% | – |
Q4 2017 | $346,000 | -30.9% | 5,083 | -16.4% | 0.00% | – |
Q3 2017 | $501,000 | +98.0% | 6,083 | +125.1% | 0.00% | – |
Q2 2017 | $253,000 | +462.2% | 2,702 | +284.9% | 0.00% | – |
Q1 2017 | $45,000 | -91.9% | 702 | -95.7% | 0.00% | – |
Q4 2016 | $558,000 | +11.8% | 16,302 | +17.6% | 0.00% | – |
Q3 2016 | $499,000 | +1060.5% | 13,863 | +338.3% | 0.00% | – |
Q2 2016 | $43,000 | -32.8% | 3,163 | -4.0% | 0.00% | – |
Q1 2016 | $64,000 | -75.7% | 3,295 | -56.0% | 0.00% | – |
Q4 2015 | $263,000 | +96.3% | 7,497 | +415.3% | 0.00% | – |
Q3 2015 | $134,000 | +306.1% | 1,455 | +227.0% | 0.00% | – |
Q1 2015 | $33,000 | +73.7% | 445 | -1.1% | 0.00% | – |
Q2 2014 | $19,000 | – | 450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |